Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension

OBJECTIVES: To examine the safety and efficacy of 5-year administration of certolizumab pegol (CZP)+methotrexate (MTX) in patients with active rheumatoid arthritis (RA). METHODS: Eligible patients from the Rheumatoid Arthritis Prevention of Structural Damage (RAPID)1 randomised controlled trial (RCT...

Descripción completa

Detalles Bibliográficos
Autores principales: Keystone, Edward, Landewé, Robert, van Vollenhoven, Ronald, Combe, Bernard, Strand, Vibeke, Mease, Philip, Shaughnessy, Laura, VanLunen, Brenda, van der Heijde, Désirée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251202/
https://www.ncbi.nlm.nih.gov/pubmed/23918037
http://dx.doi.org/10.1136/annrheumdis-2013-203695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251202/
https://www.ncbi.nlm.nih.gov/pubmed/23918037
http://dx.doi.org/10.1136/annrheumdis-2013-203695

Ejemplares similares